Imatinib and prostate cancer: lessons learned from targeting the platelet-derived growth factor receptor. [electronic resource]
Producer: 20131217Description: 787-94 p. digitalISSN:- 1744-7658
- Animals
- Antineoplastic Agents -- pharmacology
- Benzamides -- pharmacology
- Clinical Trials as Topic
- Disease-Free Survival
- Drug Evaluation, Preclinical
- Humans
- Imatinib Mesylate
- Male
- Molecular Targeted Therapy
- Piperazines -- pharmacology
- Platelet-Derived Growth Factor -- metabolism
- Prostatic Neoplasms -- drug therapy
- Pyrimidines -- pharmacology
- Receptors, Platelet-Derived Growth Factor -- antagonists & inhibitors
- Signal Transduction -- drug effects
- Survival Rate
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.